Brian van Rooyen, CEO of Labat Africa, which has positioned itself to be a major player in the potentially lucrative local market for cannabis products, says its plans will not be affected by a recent US Food and Drug Administration warning that some of these products have serious health risks.

“The FDA has flagged THC, the stuff that makes you high, for recreational purposes, but people will continue to use it for medical purposes. And our focus has been primarily on the medical pharmaceutical side,” Van Rooyen says...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.